1,952
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Hypouricaemic action of mangiferin results from metabolite norathyriol via inhibiting xanthine oxidase activity

, , , , , & show all
Pages 1680-1686 | Received 22 Aug 2014, Accepted 10 Nov 2015, Published online: 26 Feb 2016

References

  • Borges F, Fernandes E, Roleira F. 2002. Progress towards the discovery of xanthine oxidase inhibitors. Curr Med Chem. 9:195–217.
  • Carroll JJ, Coburn J, Douglas R, Babson AL. 1971. A simplified alkaline phosphotungstate assay for uric acid in serum. Clin Chem. 17:158–160.
  • Deng SM, Yang XH, Zhao YX, Zhou J. 2006. New xanthones from Polygala crotalarioides. Chem Res Chinese Univ. 22:400–402.
  • Edwards NL. 2008. The role of hyperuricemia and gout in kidney and cardiovascular disease. Clev Clin J Med. 75 (Suppl 5):S13–S16.
  • Flemmig J, Kuchta K, Arnhold J, Rauwald HW. 2011. Olea europaea leaf (Ph.Eur.) extract as well as several of its isolated phenolics inhibit the gout-related enzyme xanthine oxidase. Phytomedicine. 18:561–566.
  • Ge DD, Zhang Y, Liu EW, Wang T, Hu LM. 2011. Chemical constituents of Mangifera indica leaves (I). Chin Tradit Herb Drugs. 42:428–431.
  • Hall IH, Scoville JP, Reynolds DJ. Simlot R, Duncan P. 1990. Substituted cyclic imides as potential anti-gout agents. Life Sci. 46:1923–1927.
  • Han DD, Chen CJ, Zhang C, Zhang Y, Tang X. 2010. Determination of mangiferin in rat plasma by liquid-liquid extraction with UPLC-MS/MS. J Pharm Biomed Anal. 51:260–263.
  • Hu L, Hu HG, Wu WF, Chai XY, Luo JF, Wu Q. 2011. Discovery of novel xanthone derivatives as xanthine oxidase inhibitors. Bioorg Med Chem Lett. 21:4013–4015.
  • Hua Y, Chen CX, Liu YQ, Chen SK, Zhou J. 2006. Three new xanthones from Polygala crotalarioides. Chin Chem Lett. 17:773–775.
  • Hua Y, Chen CX, Liu YQ, Zhou J. 2007. Two new xanthones from Polygala crotalarioides. J Asian Nat Prod Res. 9:73–75.
  • Karis E, Crittenden DB, Pillinger MH. 2014. Hyperuricemia, gout, and related comorbidities: cause and effect on a two-way street. South Med J. 107:235–241.
  • Kong LD, Zhang Y, Pan X, Tan RX, Cheng CHK. 2000. Inhibition of xanthine oxidase by liquiritigenin and isoliquiritigenin isolated from Sinofranchetia chinensis. Cell Mol Life Sci. 57:500–505.
  • Li L, Chen ZH. 2010. New application of mangiferin. CN101214254B.
  • Li L, Song LD, Liu X, Gao S. 2012. The method of total synthesis of norathyriol. CN102002031B.
  • Liu HH, Wang K, Tang YH, Sun ZL, Jian LH, Li ZX, Wu B, Huang CG. 2011. Structure elucidation of in vivo and in vitro metabolites of mangiferin. J Pharm Biomed Anal. 55:1075–1082.
  • Niu Y, Lu W, Gao L, Lin H, Liu X, Li L. 2012. Reducing effect of mangiferin on serum uric acid levels in mice. Pharm Biol. 50:1177–1182.
  • Niu Y, Zhu H, Liu J, Fan H, Sun L, Lu W, Liu X, Li L. 2011. 3,5,2′,4′-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitor. Chem Biol Interact. 189:161–166.
  • Oda M, Satta Y, Takenaka O, Takahata N. 2002. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol. 19:640–653.
  • Okamoto K, Satta Y, Takenaka O, Takahata N. 2003. An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzyme–inhibitor complex and mechanism of inhibition. J Biol Chem. 278:1848–1855.
  • Pauff JM, Hille R. 2009. Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin. J Nat Prod. 72:725–731.
  • Puig JG, Martínez MA. 2008. Hyperuricemia, gout and the metabolic syndrome. Curr Opin Rheumatol. 20:187–191.
  • Sanugul K, Akao T, Li Y, Kakiuchi N, Nakamura N, Hattori M, et al. 2005. Isolation of a human intestinal bacterium that transforms mangiferin to norathyriol and inducibility of the enzyme that cleaves a C-glucosyl bond. Biol Pharm Bull. 28:1672–1678.
  • Spanou C, Veskoukis AS, Kerasioti T, Kontou M, Angelis A, Aligiannis N, Skaltsounis AL, Kouretas D. 2012. Flavonoid glycosides isolated from unique legume plant extracts as novel inhibitors of xanthine oxidase. PLoS One 7:e32214.
  • Stavric B, Clayman S, Gradd RE, Hebert D. 1975. Some in vivo effects in the rat induced by chlorprothixene and potassium oxonate. Pharmacol Res Commun. 7:117–124.
  • Takanoa Y, Hase-Aoki K, Horiuchi H, Zhao L, Kasahara Y, Kondo S, Becker MA. 2005. Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase. Life Sci. 76:1835–1847.
  • Wang H, Ye G, Ma CH, Tang YH, Fan MS, Li ZX, Huang CG. 2007. Identification and determination of four metabolites of mangiferin in rat urine. J Pharm Biomed Anal. 45:793–798.
  • Zhou RG, Yang ZX, Yang J, Wang J, Yang B, Zhang W. 2011. Total synthesis of norathyriol. App Chem Ind. 40:1516–1518.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.